申请人:ANCHOR THERAPEUTICS INC
公开号:WO2010053548A2
公开(公告)日:2010-05-14
The invention relates generally to compounds which are allosteric modulators (e.g., negative and positive allosteric modulators, allosteric agonists, and ago-allosteric modulators) of the G protein coupled receptor PTHRl, also known as parathyroid hormone/parathyroid hormone related protein receptor. The PTHRl compounds are derived from the intracellular loops and domains of the PTHRl receptor. The invention also relates to the use of these PTHRl receptor compounds and pharmaceutical compositions comprising the PTHRl receptor compounds in the treatment of diseases and conditions associated with PTHRl receptor modulation, such as osteoporosis; humoral hypercalcemia of malignancy; osteolytic and osteoblastic metastasis to bone; primary and secondary hyperparathyroidism associated increase in bone absorption; vascular calcification; psychiatric disorders and cognitive disorders associated with hyperparathyroidism; dermatological disorders; and excess hair growth.